Rigetti Computing Rockets 16% Higher on Quantum Breakthrough—What’s Next for RGTI?

Generated by AI AgentTickerSnipe
Wednesday, Jul 16, 2025 10:44 am ET2min read

• Rigetti’s stock surges 15.8% to $14.74 on a 99.5% fidelity milestone for its 36-qubit system.
• Modular chiplet architecture unlocks path to 100+ qubit systems by year-end 2025.
• Defiance Daily Target 2X Long RGTI ETF (RGTX) soars 33% as investors bet on quantum scalability.
• Shares trade near 52-week low of $0.66 but hit intra-day high of $15.03—volatile yet pivotal moment.

RGTI’s explosive intraday rally stems from a technical milestone that could redefine quantum computing’s scalability. The stock’s 16% jump marks a turning point after years of R&D, with investors now pricing in commercialization potential ahead of the August 15 launch of its 36-qubit system.

Quantum Leap in Fidelity Drives Explosive Momentum
RGTI’s surge is directly tied to its announcement of achieving 99.5% median two-qubit gate fidelity—a 2x improvement over prior systems—on its 36-qubit modular architecture. This milestone validates Rigetti’s proprietary chiplet design, which tiles four 9-qubit modules to scale while maintaining precision. CEO Subodh Kulkarni emphasized superconducting qubits’ 1,000x speed advantage over rivals, positioning Rigetti to dominate quantum cloud services. The 100+ qubit roadmap by year-end 2025 reinforces investor optimism about commercial viability, driving a 15.8% intraday surge from $12.72.

Semiconductors Mixed, but Quantum Plays Break the Mold
While sector leader (IBM) drifts -0.03%, Rigetti’s quantum-specific advances decouple it from broader semiconductor trends. NVIDIA’s AI dominance and TSMC’s chip packaging innovations highlight sector fragmentation, but RGTI’s modular architecture offers a niche scalability edge. Investors are pricing in quantum’s disruptive potential rather than traditional chip demand cycles.

RGTX ETF and Bullish Options Capture Quantum Upside
RGTI20250725C15 and RGTI20250725C14.5 contracts lead the charge. Technicals:
• 200-day MA: $8.45 (far below)
• RSI: 59.13 (neutral)
• Bollinger Bands: Current price above middle band ($12.13)
• MACD: 0.38 (bullish crossover possible)

Aggressive bulls can pair RGTX’s 2x leverage with in-the-money calls. Top picks:
1. RGTI20250725C15 (strike $15):
- Delta: 0.50 | Theta: -0.077 | Gamma: 0.164 | Leverage: 17.32%
- High gamma amplifies gains if RGTI breaches $15.03 resistance; theta decay manageable ahead of August launch.

2. RGTI20250725C14.5 (strike $14.5):
- Delta: 0.57 | Theta: -0.0796 | Gamma: 0.166 | Leverage: 13.89%
- Optimal for near-term volatility; in-the-money structure reduces premium risk.

Action Alert: RGTI’s August 15 product launch is the next catalyst. Bulls target $16 resistance (2023 highs), while bears watch $12.13 support. Pair RGTI20250725C15 with RGTX for amplified quantum momentum.

Backtest Rigetti Computing Stock Performance
The backtest of RGTI's performance after an intraday percentage change greater than 16% shows mixed results. While the 3-day win rate is 46.26%, the 10-day win rate is slightly higher at 46.79%, and the 30-day win rate is 45.99%, indicating a moderate likelihood of positive returns in the short term. However, the maximum return during the backtest period was only 1.38%, which suggests that while there is a chance of gains, the potential upside is limited.


RGTI’s Quantum Dawn: Time to Bet on Scalability or Wait for Reality Check?
RGTI’s surge is a bet on quantum scalability, but execution risks linger. IBM’s -0.03% drift underscores sector caution, yet Rigetti’s modular roadmap offers a unique growth angle. Investors should prioritize the August 15 system launch and Q2 earnings for validation. Holders above $15 face resistance from 2023 highs, while dip buyers below $12.72 could exploit technical support. Final Edge: Fade the hype below $12—else, RGTI’s quantum leap is just beginning.

Sign up for free to continue reading

Unlimited access to AInvest.com and the AInvest app
Follow and interact with analysts and investors
Receive subscriber-only content and newsletters

By continuing, I agree to the
Market Data Terms of Service and Privacy Statement

Already have an account?